Clinical trial · Interventional
Stress Management for Cancer Survivors
Stress Management for Cancer Survivors Using a Technologically Adapted Psychosocial Intervention: A Randomized Trial Determining the Effect of Expressive Writing on Psychoneuroimmunology Based Outcomes
NCT01888523CI-TRIAL-00020610completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Determine the efficacy of a brief and inexpensive psychosocial intervention, (called expressive writing) in improving health outcomes for cancer survivors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Survivors | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Everyday experiences writing | Behavioral | — | UNRESOLVED |
| Expressive writing | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Everyday experiences writing
- description
- Involves logging in to an online survey and writing in the survey about your everyday experiences. This requires 20-30 minutes of writing a day for 4 consecutive days. You will also provide saliva samples.
- interventionNames
- Behavioral: Everyday experiences writing
- type
- EXPERIMENTAL
- label
- Expressive writing
- description
- Involves logging in to an online survey and writing in the survey about your thoughts and feelings about your cancer. This requires 20-30 minutes of writing a day for 4 consecutive days. You will also provide saliva samples.
- interventionNames
- Behavioral: Expressive writing
Primary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * have completed their cancer radiation treatment (intent to cure), * are cancer free, i.e. do not have currently have a diagnosis of primary/secondary cancer or any recurrence/relapse of cancer, * are in the re-entry phase of cancer survivorship, i.e. 2-12 months post-treatment completion, * have access to a computer and internet in a private setting, e.g. at home, * are fluent in English, * are able to provide informed consent. Exclusion Criteria: * patients scheduled to undergo any type of cancer treatment (intent to cure/palliative) in the future (e.g. surgery after completing radiation), * patients on any kind of corticosteroid medication (e.g. long-term prednisone therapy), * patients having any condition that affects function of the adrenal glands (e.g. adrenal hyperplasia), * patients with limited ability to produce saliva, e.g. patients that received radiation (or surgery) on the face region or on salivary glands; or patient's suffering from dry mouth (e.g. Sjögren's syndrome), * patient's suffering from inflammation of the oral cavity (e.g. gingivitis).
References
Publications (0)
Data not yet available
No reference posted for this study.